C

Codexis

D
CDXS
USD
0.02
(0.4963%)
Market Closed
30,046.00
Volume
-0.86
EPS
-
Div Yield
-3.681818
P/E
287,255,876.85
Market Cap
Today
0.4963%
1 Week
0.998%
1 Month
29.393%
6 Months
12.344%
12 Months
142.515%
Year To Date
33.224%
All Time
0%

Title:
Codexis

Sector:
Healthcare
Industry:
Biotechnology
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.
Do you need help or have a question?